Trailing its RSV vaccine rivals, Bavarian Nordic cuts China ...

Bavarian Nordic has licensed rights to its respiratory syncytial virus (RSV) vaccine in China and certain other Asian markets to Shanghai's Nuance Pharma in a $225 million deal.

J&J's Ebola vaccine approved in EU

The European Commission has approved Johnson & Johnson's Ebola vaccine, developed by its Janssen pharmaceuticals unit and Bavarian Nordic.

GSK completes travel vaccine offload as revamp continues

GSK sells travel vaccines to Bavarian Nordic

GlaxoSmithKline (GSK) has sold off two travel vaccines to Bavarian Nordic, as the company shifts its focus away from drugs it acquired through a multi-billion “asset swap” deal with Novarti

Janssen and Bavarian Nordic sign $836m deal on Hep B and HIV...

Janssen has signed a new deal with Bavarian Nordic worth up to $836 million to develop target vaccines for hepatitis B and HIV.

BMS looks to Opdivo + vaccine combo for non-PD-L1 lung cance...

Bristol-Myers Squibb is teaming up with France’s Transgene to combine Opdivo with investigational therapeutic vaccine TG4010 in lung cancer.